All-trans retinoic acid: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

13

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 2

Conditions being studied

Condition	Trials
Chemotherapy-Induced Thrombocytopenia	2
Persistent Isolated Chemotherapy-Induced Thrombocytopenia	2
Breast Cancer	1
Cervical Cancer	1
Colorectal Cancer	1
Fallopian Tube Cancer	1
Gastrointestinal Neoplasms	1
Gynecologic Cancers	1
Lung Cancer	1
Non-Small Cell Lung Cancer	1
Ovarian Cancer	1
Pancreatic Cancer	1
Primary Peritoneal Cancer	1

Recruiting trials involving All-trans retinoic acid

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
NCT07586813 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
NCT07586826 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve All-trans retinoic acid?

2 recruiting trials across 13 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.